Capstone Investment Advisors »

Esperion Therapeutics shares owned by Capstone Investment Advisors

Quarter-by-quarter ownership of Esperion Therapeutics (ESPR) shares owned by Capstone Investment Advisors from 13F filings

Historical chart of Capstone Investment Advisors investment in Esperion Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Esperion Therapeutics held by Capstone Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Esperion Therapeutics by Capstone Investment Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $91k 34k 2.65
2023-03-31 $59k 37k 1.59
2022-12-31 $232k 37k 6.23
2021-03-31 $679k 24k 28.06